tiprankstipranks
Trending News
More News >
HQL
Tekla Life Sciences Investors of Benef Interest
Advertisement

HQL Technical Analysis

Summary of all the Indicators

Summary
Strong Buy
15Bullish
5Neutral
2Bearish
Oscillators
Neutral
3Bullish
5Neutral
2Bearish
Moving Averages
Strong Buy
12Bullish
0Neutral
0Bearish
Tekla Life Sciences Investors of Benef Interest’s (HQL) Moving Averages Convergence Divergence (MACD) indicator is 0.01, suggesting Tekla Life Sciences Investors of Benef Interest is a Sell.
Tekla Life Sciences Investors of Benef Interest’s (HQL) 20-Day exponential moving average is 16.50, making it a Buy.
Tekla Life Sciences Investors of Benef Interest’s (HQL) 50-Day exponential moving average is 16.42, making it a Buy.

Tekla Life Sciences Investors of Benef Interest (HQL) Pivot Points

Mar 20, 2026, 03:43 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
15.98
16.20
16.38
16.60
16.79
17.01
17.19
Fibonacci
16.20
16.35
16.45
16.60
16.76
16.85
17.01

Tekla Life Sciences Investors of Benef Interest (HQL) Moving Averages

Mar 20, 2026, 03:43 AM
Period
Simple
Exponential
MA5
16.61Buy
16.56Buy
MA10
16.42Buy
16.51Buy
MA20
16.55Buy
16.50Buy
MA50
16.45Buy
16.42Buy
MA100
16.35Buy
15.97Buy
MA200
14.57Buy
14.47Buy
Tekla Life Sciences Investors of Benef Interest’s (HQL) 10-Day exponential moving average is 16.51, making it a Buy.
Tekla Life Sciences Investors of Benef Interest’s (HQL) 100-Day exponential moving average is 15.97, making it a Buy.
Tekla Life Sciences Investors of Benef Interest’s (HQL) 50-day simple moving average is 16.45, creating a Buy signal.
Tekla Life Sciences Investors of Benef Interest’s (HQL) 100-day simple moving average is 16.35, creating a Buy signal.
Tekla Life Sciences Investors of Benef Interest’s (HQL) 200-day simple moving average is 14.57, creating a Buy signal.

Tekla Life Sciences Investors of Benef Interest (HQL) Technical Analysis

Mar 20, 2026, 03:43 AM
Name
Value
Action
RSI (14)
52.61
Neutral
STOCH (9,6)
68.25
Neutral
STOCHRSI (14)
62.51
Neutral
MACD (12,26)
0.01
Sell
ADX (14)
12.34
Buy
Williams %R
-23.81
Buy
CCI (14)
9.75
Neutral
ATR (14)
0.45
-
Ultimate Oscillator
48.48
Neutral
ROC
-1.07
Sell
Tekla Life Sciences Investors of Benef Interest’s (HQL) Relative Strength Index (RSI) is 52.61, creating a Neutral signal.
Tekla Life Sciences Investors of Benef Interest’s (HQL) Trend Strength Indicator (ADX) is 12.34, creating a Buy signal.
Tekla Life Sciences Investors of Benef Interest’s (HQL) Commodity Channel Index (CCI) is 9.75, creating a Neutral signal.
Tekla Life Sciences Investors of Benef Interest’s (HQL) Price Rate of Change (ROC) is -1.07, creating a Sell signal.

FAQ

Is HQL a Buy, Hold, or Sell?
Based on HQL’s technical indicators, HQL is a Strong Buy.
    What is HQL’s RSI (14)?
    HQL’s RSI (14) is 52.61, which suggests HQL is a Neutral.
      What is HQL’s MACD?
      HQL’s MACD is 0.01, which suggests HQL is a Sell.
        What is HQL’s 5-day moving average?
        HQL’s 5-day moving average is 16.61, which suggests HQL is a Buy.
          What is HQL’s 20-day moving average?
          HQL 20-day moving average is 16.55, which suggests HQL is a Buy.
            What is HQL’s 50-day moving average?
            HQL’s 50-day moving average is 16.45, which suggests HQL is a Buy.
              What is HQL’s 200-day moving average?
              HQL’s 200-day moving average is 14.57, which suggests HQL is a Buy.
                What is HQL’s Williams % R (14)?
                HQL’s Williams % R (14) is -23.81, which suggests HQL is a Buy.
                  What is HQL’s CCI (14)?
                  HQL’s CCI (14) is 9.75, which suggests HQL is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis
                    Advertisement